Sulphation factor activity and growth rate during long-term treatment of patients with pituitary dwarfism with human growth hormone.
D000728:Androgens / Q000494:pharmacology; D000917:Antibody Formation / Q000187:drug effects; D001798:Blood Proteins / Q000378:metabolism*; D001827:Body Height; D001835:Body Weight; D001846:Bone Development / Q000187:drug effects; D003348:Cortisone / Q000494:pharmacology; D004393:Dwarfism, Pituitary / Q000188:drug therapy* / Q000503:physiopathology; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D006128:Growth / Q000187:drug effects*; D013006:Growth Hormone / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007328:Insulin; D007456:Iodine Isotopes; D008297:Male; D011863:Radioimmunoassay; D013002:Somatomedins / Q000097:blood / Q000378:metabolism; D013431:Sulfates / Q000378:metabolism*; D013974:Thyroxine / Q000494:pharmacology; D013997:Time Factors
D000728:Androgens; D001798:Blood Proteins; D004967:Estrogens; D007328:Insulin; D007456:Iodine Isotopes; D013002:Somatomedins; D013431:Sulfates; D013006:Growth Hormone; D013974:Thyroxine; D003348:Cortisone